Science, research and developmentEuropean Commission Chile-EC S&T Agreement Brussels, 24 September 2002 Life Sciences, Genomics and Biotechnology for Health

Chile-EC S&T AgreementBrussels, 24 September 2002

Science, research and development European Commission

Life Sciences, Genomics andBiotechnology for Health

Dr Alfredo AguilarHead of Unit

Biotechnology and Applied GenomicsResearch Directorate General

European Commission



Framework Programme 2002-2006

Focussing and Integrating CommunityFocussing and Integrating Community Research

To assemble a critical mass of resources andsupport integration of EU research capacities in

• 7 priority areas • supporting policies and anticipating needs • SME• International cooperation• JRC (non-nuclear research)

Structuring ERAStructuring ERA

To structure the ERA in:

• Research & Innovation • Training & Mobility• Infrastructures• Science & Society

Strenghtening the ERA FoundationsStrenghtening the ERA Foundations

• To co-ordinate EU research activities

• To support the development of research/innovation policies



7 Priority Thematic Areas

1. Life Sciences, Genomics and Biotechnology 2255for Health

2. Information Society Technologies 36253. Nanotechnologies, Multifunctional Materials and New Production Systems and devices 1300

4. Aeronautics and Space 1075

5. Food Quality and Safety 6856. Sustainable Development,Global Change and Ecosystems 2120

7. Citizens and Governance in a Knowledge Society 225

Budget proposed(EUR million)



Framework Programme 6 (2002-2006)

Thematic priorities

Focus on strategic areas where immediate and longer term integration of European research is needed to generate and sustain necessary critical mass

New knowledge >> understanding >>application



Priority ‘Life Sciences, Genomics and Biotechnology for Health’

To help Europe to exploit

breakthroughs in decoding the

genomes of living organisms for the

benefit of :

- public health

- citizens

- increase the competitiveness of

European

biotechnology industry



Priority 1: Life Sciences, Genomics and Biotechnology for Health

Advanced genomics and its application for health (1100 Millions Euros):

• Fundamental knowledge and basic tools for functional genomics in all organisms

• Applications of knowledge and technologies in the field of genomics and biotechnology for health

Combating major diseases (1155 Millions Euros):• Application-oriented genomic approaches to medical knowledge

and technologies• Confronting the major communicable diseases linked to poverty



Fundamental knowledge and basic tools forfunctional genomics in all organisms

Objective: Understanding of genomic information, by developing the knowledge base, tools and resources needed to decipher the function of genes and gene products.

- Research actions: gene expression and proteomics- Structural genomics- Comparative genomics- Comparative genomics and population genetics- Bioinformatics

- Multidisciplinary functional genomics approaches to basic biological process

APPLICATIONS

Medicine

AgricultureQuality of Life

Environment



Applications of knowledge and technologiesin the field of genomics and biotechnology for

health (i)

Objective: Foster the competitiveness of Europe’s biotechnology industry by exploiting the wealth of biological data produced by genomics and advances in biotechnology.

- Research actions: Technological platforms for the development in the fields of new diagnostics, prevention and therapeutic tools

… with an active and early involvement of regulators, experts on ethics, patients and society at large.

APPLICATIONS

Health Care

DiagnosticsCost Reduction

Individualised treatment

New drugs and therapies



Technological platforms for developments in the field of new diagnostic, prevention and therapeutic tools :

Applications of knowledge and technologiesin the field of genomics and biotechnology for

health (ii)

• Rational and accelerated development of new, safer, more effective drugs including pharmacogenomics approaches

• Development of new diagnostics• Development of new in vitro tests to replace animal testing• Development and testing of new preventive and therapeutic tools

(such as somatic gene and cell therapies [stem cells therapies])• Immunotherapies• Innovative research in post-genomics, which has high potential for

application



Application-oriented genomic approachesto medical knowledge and technologies

Objective: to develop improved strategies for the prevention and management of human disease and for living and ageing healthy.

Research actions: - Combating cardiovascular diseases, diabetes and rare diseases

- Combating resistance to antibiotics and other drugs- Studying the brain and combating diseases of the nervous system- Studying human development and the ageing process- Combating cancer

APPLICATIONS

Bringing basic knowledge through to clinical applications

Improved patient-oriented strategies



Confronting the major communicable diseases linked to poverty

Objective:

To confront the global emergency caused by the three major communicable diseases HIV/AIDS, malaria and tuberculosis through the development of effective disease interventions, particularly for use in developing countries.



Ongoing and coming trends...• 7 June 2002 deadline for the “Invitation to submit Expressions of Interest”. • November 2002, First Call for Proposals, Framework Programme 6

To keep you informed with the latest news…

www.cordis.lu/fp6/eoi-instruments

… and with the new instruments, rules for participation,…

http://europa.eu.int/comm/research/nfp/networks-ip.html

Help and information :

for Priority “Life Sciences, Genomics and Biotechnology for Health”: [email protected]

Opportunities for Life Sciences, Genomics and Biotechnology for Healthin Framework Programme 6 (2002-2006)

Documents

Science, research and developmentEuropean Commission Chile-EC S&T Agreement Brussels, 24 September 2002 Life Sciences, Genomics and Biotechnology for Health